AstraZeneca Pharma India appointed Dr. Shashank Srinivasan as Medical Director – Oncology Business Unit and promoted Mr. Venkat Natarajan to Director – Market Access Business Unit. These strategic appointments strengthen key business units, enhancing leadership in oncology and market access.